Skip to main content

Table 1 Results of the additive, dominant and recessive TTT models. Polymorphisms with a BH-adjusted P-value < 0.1 are show

From: The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

rs ID

P-value

BH-adjusted P-value

Reference

Alternative

Gene Symbol

Hazard Ratio

MAF

ADDTIVE MODEL

rs537453728

4.53E-08

5.39 E-3

CT

C

MAP3K4

7.08

0.01

rs361807

4.31E-07

0.01

T

C

PEX26

4.55

0.1

rs361946

4.31E-07

0.01

A

G

PEX26

4.55

0.1

rs1043278

4.31E-07

0.01

A

G

PEX26

4.55

0.1

rs7620924

5.08E-07

0.01

A

G

PPP4R2

0.24

0.49

rs5992169

9.55E-07

0.02

G

A

PEX26

4.45

0.11

rs9463

3.11E-06

0.05

G

A

TTLL12

3.18

0.42

rs55715863

3.84E-06

0.05

C

A

TXNRD2

5.24

0.01

rs3780333

3.84E-06

0.05

A

G

ZCCHC7

4.8

0.27

rs17016977

5.69E-06

0.07

A

G

MKI67IP

5.53

0.01

rs72842201

6.13E-06

0.07

A

G

MARCH.10

2.99

0.05

rs3172278

7.23E-06

0.07

T

C

PPP4R2

4.04

0.49

DOMINANT MODEL

rs3172278

2.40E-08

1.23E-03

T

C

PPP4R2

0.09

0.49

rs2247870

1.60E-07

4.10E-03

G

A

GPR98

0.4

0.47

rs9463

3.07E-07

5.26E-03

G

A

TTLL12

0.17

0.42

rs28656102

1.22E-06

0.02

T

C

PPP4R2

0.18

0.42

rs1045960

6.22E-06

0.05

C

T

PPP4R2

0.21

0.42

rs62039297

6.29E-06

0.05

G

A

SRL

0.2

0.26

rs9873229

9.72E-06

0.07

C

T

PPP4R2

0.22

0.44

RECESSIVE MODEL

rs7620924

8.07E-11

1.08E-05

A

G

PPP4R2

11.77

0.49

rs537453728

4.53E-08

3.04E-03

CT

C

MAP3K4

0.14

0.01

rs9310254

7.49E-07

0.03

T

C

PPP4R2

5.56

0.49